Amrize (NYSE:AMRZ) Insider Jaime Hill Purchases 1,500 Shares

Amrize Ltd (NYSE:AMRZGet Free Report) insider Jaime Hill bought 1,500 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was acquired at an average cost of $47.12 per share, for a total transaction of $70,680.00. Following the purchase, the insider owned 29,698 shares of the company’s stock, valued at $1,399,369.76. This trade represents a 5.32% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Amrize Stock Up 0.8%

Shares of AMRZ opened at $46.75 on Friday. The stock has a market cap of $25.85 billion, a price-to-earnings ratio of 21.54, a P/E/G ratio of 0.99 and a beta of 0.11. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. Amrize Ltd has a 12 month low of $46.03 and a 12 month high of $65.94. The company has a 50-day moving average price of $51.35 and a two-hundred day moving average price of $54.52.

Amrize (NYSE:AMRZGet Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.17%. The company had revenue of $3.50 billion during the quarter. Equities analysts predict that Amrize Ltd will post 2.72 EPS for the current fiscal year.

Amrize Dividend Announcement

The business also recently declared a dividend, which will be paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th will be paid a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize’s payout ratio is currently 20.28%.

Key Stories Impacting Amrize

Here are the key news stories impacting Amrize this week:

  • Positive Sentiment: Stephens maintained a Buy rating on Amrize, reinforcing a favorable analyst view of the building-materials company. Stephens maintains Buy rating on Amrize
  • Positive Sentiment: Several Amrize insiders purchased shares on August 11, signaling that company executives may view the recent decline as an attractive entry point. CFO Baris Oran bought 3,000 shares for approximately $142,140, while CTO Roald Brouwer purchased 1,500 shares for about $69,540.
  • Positive Sentiment: Additional insider purchases included 5,260 shares by Stephen S. Clark, valued at approximately $248,851; 3,568 shares by Mario Gross, valued at about $166,269; and 1,500 shares by Jaime Hill, valued at roughly $70,680. Collectively, the transactions represent more than $597,000 of insider buying and increased the respective executives’ holdings. Amrize insider purchase filing

Institutional Investors Weigh In On Amrize

A number of hedge funds have recently added to or reduced their stakes in AMRZ. Norges Bank bought a new position in shares of Amrize in the fourth quarter worth about $929,333,000. Harris Associates L P bought a new stake in shares of Amrize during the fourth quarter valued at approximately $615,406,000. Wellington Management Group LLP increased its holdings in shares of Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after purchasing an additional 3,809,133 shares in the last quarter. Marshall Wace LLP increased its holdings in shares of Amrize by 865.4% in the third quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock valued at $139,436,000 after purchasing an additional 2,590,336 shares in the last quarter. Finally, Barclays PLC increased its holdings in shares of Amrize by 95.4% in the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock valued at $249,557,000 after purchasing an additional 2,253,431 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research firms have issued reports on AMRZ. Weiss Ratings lowered Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, July 31st. Stephens reduced their target price on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research note on Wednesday. Truist Financial reaffirmed a “hold” rating and issued a $48.00 target price (down from $65.00) on shares of Amrize in a report on Tuesday, July 7th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Finally, Citigroup cut their price target on shares of Amrize from $66.00 to $58.00 and set a “buy” rating for the company in a report on Tuesday. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Amrize presently has an average rating of “Moderate Buy” and an average target price of $60.57.

View Our Latest Stock Analysis on Amrize

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.